Projected to grow from US$3.36 billion in 2024 to US$13.16 billion by 2033 at 16.5% CAGR, the liver cancer therapeutics market thrives on hospital pharmacies and intravenous routes. Dive into segmentation by cancer type, challenges like high costs, and R&D in proton therapy. https://finance.yahoo.com/news/liver-cancer-therapeutics-market-size-140100776.html